Infectious Dis. Medical News about Vancomycin

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Activity of Telavancin against Staphylococcus aureus Strains with Various Vancomycin Susceptibilities in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
Antimicrobial Agents and Chemotherapy, 06/25/09

Leonard SN et al. - The results suggest that telavancin may have therapeutic potential, especially against strains with reduced susceptibility to vancomycin. Combination therapy, particularly with gentamicin, may improve bacterial killing against certain strains.

<< Previous
Proteomic identification of OprL as a seromarker for the initial...

Next >>
Poverty and psychological health among AIDS-orphaned children in...

Therapeutic Monitoring of Vancomycin in Adults Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
Pharmacotherapy, 10/29/09 Relevance Score: 89%

Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: A retrospective chart review
Clinical Therapeutics, 10/29/09 Relevance Score: 88%

Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics
Current Opinion in Infectious Diseases, 11/02/09 Relevance Score: 85%

Aerosolized vancomycin for the treatment of MRSA after lung transplantation
Respirology, 11/10/09 Relevance Score: 84%

Evaluation of Vancomycin and Daptomycin Potency Trends against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006
Antimicrobial Agents and Chemotherapy, 10/09/09 Relevance Score: 83%